CytoDyn Inc. (OTCMKTS:CYDY) Short Interest Update

CytoDyn Inc. (OTCMKTS:CYDYGet Rating) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 40,549,900 shares, a decrease of 8.8% from the August 15th total of 44,456,900 shares. Based on an average trading volume of 3,605,800 shares, the short-interest ratio is currently 11.2 days.

CytoDyn Price Performance

OTCMKTS CYDY opened at $0.58 on Wednesday. The stock’s fifty day moving average price is $0.67 and its 200 day moving average price is $0.48. CytoDyn has a 1 year low of $0.23 and a 1 year high of $2.54.

CytoDyn Company Profile

(Get Rating)

CytoDyn Inc operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19).

Featured Stories

Receive News & Ratings for CytoDyn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytoDyn and related companies with MarketBeat.com's FREE daily email newsletter.